A single dose of the Pfizer-BioNTech vaccine for individuals who previously had COVID-19 generates an immunologic response similar to that of individuals receiving the two-dose recommended sequence, according to a Cedars-Sinai study published today by the journal Nature Medicine.
Susan Cheng, MD, MPH, MMSc, recalls hearing the first reports of a mysterious illness in China early last year and thinking: “This is going to be important.”
Healthcare workers might not be so different from the general population in the factors that determine their risk of getting COVID-19. A new study led by Cedars-Sinai shows that healthcare workers are more likely to have antibodies to COVID-19 in their blood if they are African American or Latino or have hypertension.
A new study from the Smidt Heart Institute at Cedars-Sinai shows that women have a lower “normal” blood pressure range compared to men. The findings were published today in the peer-reviewed journal Circulation.
A widely used tuberculosis vaccine is associated with reduced likelihood of contracting COVID-19 (coronavirus), according to a new study by Cedars-Sinai. The findings raise the possibility that a vaccine already approved by the U.S. Food and Drug Administration may help prevent coronavirus infections or reduce severity of the disease.